Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2006

01-11-2006 | Short Communication

Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy

Authors: Elisabeth Isenring, Giordana Cross, Lynne Daniels, Elizabeth Kellett, Bogda Koczwara

Published in: Supportive Care in Cancer | Issue 11/2006

Login to get access

Abstract

Goals of work

To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy.

Patients and methods

An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients.

Main results

According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001).

Conclusion

The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.
Literature
1.
Ollenschlager G, Viell B, Konkol K, Burger B (1991) Tumor anorexia: causes, assessment, treatment. Recent Results Cancer Res 121:20–27
2.
Shike M (1996) Nutrition management for the cancer patient. Hematol Oncol Clin N Am 10:221–234CrossRef
3.
Bokhorst-de van der Schueren MA, van Leeuwen PA, Kuik DJ, Klop WM, Sauerwein HP, Snow GB, Quak JJ (1999) The impact of nutritional status on the prognosis of patients with advanced head and neck cancer. Cancer 86:519–527CrossRef
4.
Correia MI, Waitzburg DL (2003) The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr 22:235–239CrossRefPubMed
5.
Ottery FD (1995) Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 22:98–111PubMed
6.
Isenring E, Bauer J, Capra S (2003) The scored Patient Generated-Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 57:305–309CrossRefPubMed
7.
Isenring E, Capra S, Bauer J (2004) Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal, head or neck area. Br J Cancer 91:447–452CrossRefPubMed
8.
Ravasco P, Monterio-Grillo I, Vidal P, Camilo M (2005) Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23:1431–1438CrossRefPubMed
9.
The American Dietetic Association (1994) ADA’s definitions for nutrition screening and nutrition assessment. J Am Diet Assoc 94:838–839CrossRef
10.
Ferguson M, Capra S (1998) Nutrition screening practices in Australian hospitals. Aust J Nutr Diet 55:157–161
11.
Ferguson M, Capra S, Bauer J, Banks M (1999) Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. Nutrition 15:458–463CrossRefPubMed
12.
Ottery FD (1996) Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12:S15–S19PubMed
13.
McWhirter JP, Pennington CR (1994) Incidence and recognition of malnutrition in hospital. Br Med J 308:945–948
14.
Ottery FD (2000) Patient generated subjective global assessment. In: McCallum P, Polisena C (eds) The clinical guide to oncology nutrition. The American Dietetic Association, Chicago, IL, USA, pp 11–23
15.
Detsky AS, McLaughlin JR, Baker JP, Johnson N, Whittaker S, Mendelson RA, Jeejeebhoy KN (1987) What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11:8–13PubMedCrossRef
16.
Bauer J, Capra S, Ferguson M (2002) Use of the scored patient generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785CrossRefPubMed
17.
Persson C, Sjoden P, Glimelius B (1999) The Swedish version of the patient generated subjective global assessment of nutritional status: gastrointestinal vs urological cancers. Clin Nutr 18:71–77CrossRefPubMed
18.
Jones JM (2002) The methodology of nutritional screening and assessment tools. J Hum Nutr Diet 15:59–71CrossRefPubMed
19.
Ferguson M, Bauer J, Gallagher B, Capra S, Christie DRH, Mason BR (1999) Validation of a malnutrition screening tool for patients receiving radiotherapy. Australas Radiol 43:325–327CrossRefPubMed
20.
Raja R, Lim AV, Lim P, Lim G, Chan P, Vu CK (2004) Malnutrition screening in hospitalised patients and its implication on reimbursement. Int Med J 34:176–181CrossRef
21.
National Health and Medical Research Council (2003) Clinical practice guidelines for the management of overweight and obesity in adults. Commonwealth of Australia. Canberra, Australia
22.
Bannerman E, Miller MD, Daniels LA, Cobiac L, Giles LC, WHitehead C, Andrews GR, Crotty M (2002) Anthropometric indices predict physical function and mobility in older Australians: the Australian Longitudinal Study of Ageing. Public Health Nutr 5:655–662CrossRefPubMed
23.
Agresti A, Coull B (1998) Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 52:119–126CrossRef
24.
Segura A, Pardo J, Jara C, Zugazabeitia L, Curulla J, de las Penas R, Garcia-Cabrera E, Azuara M, Casado J, Gomez-Candela C (2005) An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advance or metastatic cancer. Clin Nutr 24:801–814CrossRefPubMed
25.
Ottery FD (1994) Cancer cachexia: prevention, early diagnosis and management. Cancer Pract 2:123–131PubMed
26.
Stratton RJ, Hackston A, Longmore D, Dixon R, Price S, Stroud M, King C, Elia M (2004) Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the “malnutrition universal screening tool’ (MUST) for adults. Br J Nutr 92:799–808CrossRefPubMed
27.
Rubestein LZ, Harker JO, Salva A, Guigoz Y, Vellas B (2001) Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol Ser A Biol Sci Med Sci 56:M366–M372
28.
Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc ESPEN Working Group (2003) Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22:321–336CrossRefPubMed
Metadata
Title
Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy
Authors
Elisabeth Isenring
Giordana Cross
Lynne Daniels
Elizabeth Kellett
Bogda Koczwara
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0070-5

Other articles of this Issue 11/2006

Supportive Care in Cancer 11/2006 Go to the issue

Original Article

Supportive care needs of people with brain tumours and their carers

Forthcoming Meetings

Forthcoming Meetings

Original Article

A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results

Original Article

Symptom profiles and palliative care in advanced pancreatic cancer—a prospective study

Short communication

Breaking bad news: evaluation study on self-perceived competences and views of medical and nursing students taking part in a collaborative workshop

Editorial

Imagine, scientists can predict my and your survival…

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits